Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases
UCLA chemists and molecular biologists have for the first time used a "structure-based" approach to drug design to identify compounds with the potential to delay or treat Alzheimer's disease, and possibly Parkinson's, Lou ...
Jul 26, 2013
0
0